SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001157523-11-001448
Filing Date
2011-03-08
Accepted
2011-03-08 08:30:56
Documents
6
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-K a6636116.htm 10-K 1596635
2 EXHIBIT 3.3 a6636116ex3-3.htm EX-3.3 139499
3 EXHIBIT 23.1 a6636116ex23-1.htm EX-23.1 3975
4 EXHIBIT 31.1 a6636116ex31-1.htm EX-31.1 15548
5 EXHIBIT 32.1 a6636116ex32-1.htm EX-32.1 7749
6 LOGO logo.gif GRAPHIC 4102
  Complete submission text file 0001157523-11-001448.txt   1770492
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33004 | Film No.: 11670446
SIC: 2834 Pharmaceutical Preparations